{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pred-forte&page=16", "query": { "intervention": "Pred-forte", "page": 16 }, "page_size": 10 }, "pagination": { "page": 16, "page_size": 10, "total_count": 729, "total_pages": 73, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pred-forte&page=17&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pred-forte&page=15&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-23T11:37:27.270Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07461961", "title": "CORTISHOCK-P: Trial of Corticosteroids in Inflammation-Enriched Heart Failure Cardiogenic Shock", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Cardiogenic Shock", "Heart Failure", "Inflammation" ], "interventions": [ { "name": "Methylprednisone", "type": "DRUG" }, { "name": "Standard of Care (SOC)", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 30, "start_date": "2026-10-01", "completion_date": "2029-02-01", "has_results": false, "last_update_posted_date": "2026-08-13", "last_synced_at": "2026-10-23T11:37:27.270Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07461961" }, { "nct_id": "NCT00492973", "title": "Do Corticosteroid Injections During Total Knee Replacement Improve Early Clinical Results?", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Osteoarthritis", "Post-traumatic; Arthrosis" ], "interventions": [ { "name": "methylprednisolone acetate", "type": "DRUG" }, { "name": "active comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "New Lexington Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "95 Years", "sex": "ALL", "summary": "18 Years to 95 Years" }, "enrollment_count": 101, "start_date": "2006-03", "completion_date": "2008-02", "has_results": true, "last_update_posted_date": "2013-12-19", "last_synced_at": "2026-10-23T11:37:27.270Z", "location_count": 1, "location_summary": "Lexington, Kentucky", "locations": [ { "city": "Lexington", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00492973" }, { "nct_id": "NCT00915473", "title": "Greater Occipital Nerve Block for Migraine Prophylaxis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Migraine Headache" ], "interventions": [ { "name": "bupivicaine", "type": "DRUG" }, { "name": "normal saline", "type": "DRUG" }, { "name": "methylprednisolone", "type": "DRUG" }, { "name": "lidocaine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 70, "start_date": "2009-06", "completion_date": "2013-01", "has_results": true, "last_update_posted_date": "2014-03-20", "last_synced_at": "2026-10-23T11:37:27.270Z", "location_count": 1, "location_summary": "Phoenix, Arizona", "locations": [ { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT00915473" }, { "nct_id": "NCT04127578", "title": "Phase 1/2a Clinical Trial of PR001 (LY3884961) in Patients With Parkinson's Disease With at Least One GBA1 Mutation (PROPEL)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Parkinson Disease" ], "interventions": [ { "name": "LY3884961", "type": "BIOLOGICAL" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Sirolimus", "type": "DRUG" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "Prevail Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "35 Years to 80 Years" }, "enrollment_count": 32, "start_date": "2020-01-03", "completion_date": "2031-08-31", "has_results": false, "last_update_posted_date": "2026-10-13", "last_synced_at": "2026-10-23T11:37:27.270Z", "location_count": 11, "location_summary": "Scottsdale, Arizona • Murrieta, California • Englewood, Colorado + 7 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Murrieta", "state": "California" }, { "city": "Englewood", "state": "Colorado" }, { "city": "Maitland", "state": "Florida" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04127578" }, { "nct_id": "NCT04521140", "title": "Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Corneal Transplant Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Corneal Edema", "Corneal Defect", "Corneal Transplant", "Penetrating KeratoPlasty", "Anterior Chamber Inflammation", "Ocular Pain", "Intraocular Pressure" ], "interventions": [ { "name": "Dextenza 0.4Mg Ophthalmic Insert", "type": "DRUG" }, { "name": "Prednisolone Acetate 1% Oph Susp", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Nicole Fram M.D.", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 36, "start_date": "2020-10-16", "completion_date": "2023-01-04", "has_results": false, "last_update_posted_date": "2023-07-24", "last_synced_at": "2026-10-23T11:37:27.270Z", "location_count": 1, "location_summary": "Los Angeles, California", "locations": [ { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04521140" }, { "nct_id": "NCT00076752", "title": "Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lupus Erythematosus, Systemic" ], "interventions": [ { "name": "fludarabine phosphate", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "Rituxan (rituximab)", "type": "BIOLOGICAL" }, { "name": "filgrastim", "type": "BIOLOGICAL" }, { "name": "methylprednisolone", "type": "DRUG" }, { "name": "immunologic technique", "type": "OTHER" }, { "name": "laboratory biomarker analysis", "type": "OTHER" }, { "name": "autologous hematopoietic stem cell transplantation", "type": "PROCEDURE" }, { "name": "Diphenhydramine", "type": "DRUG" }, { "name": "Mesna", "type": "DRUG" } ], "intervention_types": [ "DRUG", "BIOLOGICAL", "OTHER", "PROCEDURE" ], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": "40 Years", "sex": "ALL", "summary": "15 Years to 40 Years" }, "enrollment_count": 9, "start_date": "2004-01-30", "completion_date": "2013-10-15", "has_results": true, "last_update_posted_date": "2021-01-05", "last_synced_at": "2026-10-23T11:37:27.270Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00076752" }, { "nct_id": "NCT03324503", "title": "A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subjects With Pulmonary Sarcoidosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sarcoidosis, Pulmonary" ], "interventions": [ { "name": "Glucocorticoid (prednisone or prednisolone)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celgene", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 8, "start_date": "2017-12-08", "completion_date": "2019-11-15", "has_results": false, "last_update_posted_date": "2020-02-26", "last_synced_at": "2026-10-23T11:37:27.270Z", "location_count": 10, "location_summary": "Birmingham, Alabama • Iowa City, Iowa • Baltimore, Maryland + 7 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Iowa City", "state": "Iowa" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Wilmington", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03324503" }, { "nct_id": "NCT03229538", "title": "STeroids to REduce Systemic Inflammation After Infant Heart Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Congenital Heart Disease in Children", "Inflammatory Response" ], "interventions": [ { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Isotonic saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kevin Hill", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "12 Months", "sex": "ALL", "summary": "Up to 12 Months" }, "enrollment_count": 1263, "start_date": "2017-10-18", "completion_date": "2022-03-31", "has_results": true, "last_update_posted_date": "2026-01-05", "last_synced_at": "2026-10-23T11:37:27.270Z", "location_count": 23, "location_summary": "Los Angeles, California • Aurora, Colorado • Gainesville, Florida + 20 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Oak Lawn", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03229538" }, { "nct_id": "NCT00002524", "title": "Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lymphoma" ], "interventions": [ { "name": "Bleomycin Sulfate", "type": "BIOLOGICAL" }, { "name": "Filgrastim", "type": "BIOLOGICAL" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Cyclophosphamide", "type": "DRUG" }, { "name": "Cytarabine", "type": "DRUG" }, { "name": "Doxorubicin Hydrochloride (DOX)", "type": "DRUG" }, { "name": "Etoposide", "type": "DRUG" }, { "name": "Fluorouracil", "type": "DRUG" }, { "name": "Ifosfamide", "type": "DRUG" }, { "name": "Leucovorin calcium", "type": "DRUG" }, { "name": "Methotrexate", "type": "DRUG" }, { "name": "Methylprednisolone", "type": "DRUG" }, { "name": "Pentamidine", "type": "DRUG" }, { "name": "Prednisone", "type": "DRUG" }, { "name": "Trimethoprim-Sulfamethoxazole", "type": "DRUG" }, { "name": "Vincristine Sulfate", "type": "DRUG" }, { "name": "Zidovudine (AZT)", "type": "DRUG" }, { "name": "Radiation Therapy", "type": "RADIATION" } ], "intervention_types": [ "BIOLOGICAL", "DRUG", "RADIATION" ], "sponsor": "M.D. Anderson Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "ALL", "summary": "15 Years and older" }, "enrollment_count": 46, "start_date": "1993-06", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2012-07-30", "last_synced_at": "2026-10-23T11:37:27.270Z", "location_count": 2, "location_summary": "Orlando, Florida • Houston, Texas", "locations": [ { "city": "Orlando", "state": "Florida" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002524" }, { "nct_id": "NCT01381874", "title": "A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Metastatic ER+ Her2- Breast Cancer", "Postmenopausal" ], "interventions": [ { "name": "Exemestane", "type": "DRUG" }, { "name": "Abiraterone acetate + Prednisone/ Prednisolone + Exemestane", "type": "DRUG" }, { "name": "Abiraterone acetate + Prednisone or Prednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 297, "start_date": "2011-08-24", "completion_date": "2018-08-08", "has_results": true, "last_update_posted_date": "2019-04-11", "last_synced_at": "2026-10-23T11:37:27.270Z", "location_count": 24, "location_summary": "Muscle Shoals, Alabama • Fresno, California • Los Angeles, California + 21 more", "locations": [ { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Monterey", "state": "California" }, { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT01381874" } ] }